TSHA (TSHA) Stock Price & Analysis
TSHA (TSHA) rose 0.00% to USD 5.52 as of July 25, 2026 at 05:07 UTC, according to Nexqual real-time market data.
TSHA last closed at USD 5.52; the session ranged USD 5.46–5.95 on volume of 1,811,366 shares. Market capitalization is —, with a 52-week range of USD 2.53–7.3 (NMS). Source: Nexqual, July 25, 2026 at 05:07 UTC.
Key Statistics (as of July 25, 2026 at 05:07 UTC)
| Price | USD 5.52 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 5.52 |
| Open | USD 5.52 |
| Day Range | USD 5.46 – 5.95 |
| 52-Week Range | USD 2.53 – 7.3 |
| Volume | 1,811,366 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TSHA)
Nexqual's technical model rates TSHA "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 05:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.75 (neutral) |
| vs SMA50 | Below (USD 5.98) |
| MACD | -0.14 (negative) |
From TSHA's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | USD 3.4 | ▼ 9.09% |
| STTK | Shattuck Labs, Inc. | USD 7.43 | ▲ 5.84% |
| PRLD | Prelude Therapeutics Incorporat | USD 3.83 | ▼ 2.42% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 10.07 | ▼ 8.12% |
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.1 | ▲ 12.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:07 UTC. This page is informational and not investment advice.